STOCK TITAN

Boston Scientific to Participate in Stifel's 2023 Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Boston Scientific Corporation (NYSE: BSX) will participate in Stifel's 2023 Healthcare Conference on November 14, 2023. The company's executive vice president and CFO, Dan Brennan, and vice president of Investor Relations, Lauren Tengler, will engage in a 30-minute Q&A session. The session will be webcasted live on the Investor Relations section of Boston Scientific's website. A replay will be available one hour after the event.
Positive
  • None.
Negative
  • None.

MARLBOROUGH, Mass., Nov. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Stifel's 2023 Healthcare Conference on Tuesday, November 14, 2023.

Dan Brennan, executive vice president and chief financial officer, and Lauren Tengler, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst at approximately 8:00 a.m. ET. A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS:
Media:
Katie Schur
508-683-5574 (office)
Media Relations
Boston Scientific Corporation
Katie.Schur@bsci.com

Investor Relations:
Lauren Tengler
508-683-4479 (office)
Investor Relations
Boston Scientific Corporation
BSXInvestorRelations@bsci.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-stifels-2023-healthcare-conference-301972509.html

SOURCE Boston Scientific Corporation

Boston Scientific will participate in Stifel's 2023 Healthcare Conference on November 14, 2023.

Dan Brennan, executive vice president and chief financial officer, and Lauren Tengler, vice president of Investor Relations, will represent Boston Scientific.

The Q&A session will be available for live viewing on the Investor Relations section of Boston Scientific's website.

Yes, a replay of the session will be available on Boston Scientific's website approximately one hour after the event.
Boston Scientific Corp.

NYSE:BSX

BSX Rankings

BSX Latest News

BSX Stock Data

105.64B
1.46B
0.19%
93.66%
0.85%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
MARLBOROUGH

About BSX

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.